Baker Bros. Advisors »

Eikon Therapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.9M 556k 10.58

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Insmed Incorporated Com Par $.01 (INSM)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kodiak Sciences (KOD)
Kymera Therapeutics (KYMR)
Summit Therapeutics (SMMT)
Praxis Precision Medicines I (PRAX)
Rhythm Pharmaceuticals (RYTM)
Alkermes SHS (ALKS)
Grail (GRAL)
Edgewise Therapeutics (EWTX)

View all positions for Baker Bros. Advisors

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
Alliancebernstein
Vanguard Capital Management
EcoR1 Capital
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board
Franklin Resources
Citadel Advisors

View all funds holding Eikon Therapeutics